JB CHEMICALS & PHARMACEUTICALS
Quarterly Results Analysis [Mar2025]
JB CHEMICALS & PHARMACEUTICALS Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 Audited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹949 Cr | ₹963 Cr | ₹1,001 Cr | ₹1,004 Cr | ₹862 Cr | ₹845 Cr | ₹882 Cr | ₹896 Cr |
Expenses | ₹723 Cr | ₹709 Cr | ₹730 Cr | ₹724 Cr | ₹664 Cr | ₹621 Cr | ₹638 Cr | ₹664 Cr |
Operating Income | ₹226 Cr | ₹255 Cr | ₹271 Cr | ₹280 Cr | ₹198 Cr | ₹223 Cr | ₹244 Cr | ₹232 Cr |
Other Income | ₹14 Cr | ₹8 Cr | ₹10 Cr | ₹6 Cr | ₹17 Cr | ₹7 Cr | ₹8 Cr | ₹6 Cr |
Interest | ₹1 Cr | ₹3 Cr | ₹2 Cr | ₹6 Cr | ₹9 Cr | ₹12 Cr | ₹10 Cr | ₹12 Cr |
Depreciation | ₹46 Cr | ₹42 Cr | ₹42 Cr | ₹41 Cr | ₹41 Cr | ₹34 Cr | ₹32 Cr | ₹31 Cr |
Profit Before Tax | ₹193 Cr | ₹218 Cr | ₹237 Cr | ₹240 Cr | ₹165 Cr | ₹184 Cr | ₹209 Cr | ₹194 Cr |
Profit After Tax | ₹146 Cr | ₹162 Cr | ₹175 Cr | ₹177 Cr | ₹126 Cr | ₹134 Cr | ₹151 Cr | ₹142 Cr |
EPS | ₹9.36 | ₹10.45 | ₹11.24 | ₹11.39 | ₹8.13 | ₹8.62 | ₹9.72 | ₹9.19 |
Industry Peers & Returns | 1W | 1M | 1Y |
JB CHEMICALS & PHARMACEUTICALS | 0.7% | -1.2% | -7.5% |
SUN PHARMACEUTICAL INDUSTRIES | 0.7% | 2.8% | 7.9% |
DIVIS LABORATORIES | -0.8% | 3.7% | 48.6% |
CIPLA | -0.2% | -0.1% | -1.9% |
TORRENT PHARMACEUTICALS | 3.4% | 11.2% | 17.9% |
DR REDDYS LABORATORIES | 0.6% | -5.2% | -4.9% |
MANKIND PHARMA | -1.7% | 14.2% | 24.9% |
ZYDUS LIFESCIENCES | 0.7% | 2.7% | -17.1% |
LUPIN | 0.3% | -0.1% | 6% |
JB CHEMICALS & PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -1.45 % |
Y-o-Y | 10.18 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹949 Cr | -1.45 | |
Dec2024 | ₹963 Cr | -3.71 | |
Sep2024 | ₹1,001 Cr | -0.38 | |
Jun2024 | ₹1,004 Cr | 16.56 | |
Mar2024 | ₹862 Cr | 2.04 | |
Dec2023 | ₹845 Cr | -4.22 | |
Sep2023 | ₹882 Cr | -1.61 | |
Jun2023 | ₹896 Cr | - |
JB CHEMICALS & PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -11.03 % |
Y-o-Y | 14.29 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹226 Cr | -11.03 | |
Dec2024 | ₹255 Cr | -5.92 | |
Sep2024 | ₹271 Cr | -3.51 | |
Jun2024 | ₹280 Cr | 41.52 | |
Mar2024 | ₹198 Cr | -11.20 | |
Dec2023 | ₹223 Cr | -8.38 | |
Sep2023 | ₹244 Cr | 4.92 | |
Jun2023 | ₹232 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -9.73 % |
Y-o-Y | 3.74 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 23.85% | -9.73 | |
Dec2024 | 26.42% | -2.29 | |
Sep2024 | 27.04% | -3.12 | |
Jun2024 | 27.91% | 21.40 | |
Mar2024 | 22.99% | -12.98 | |
Dec2023 | 26.42% | -4.34 | |
Sep2023 | 27.62% | 6.64 | |
Jun2023 | 25.9% | - |
JB CHEMICALS & PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -10.34 % |
Y-o-Y | 15.48 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹146 Cr | -10.34 | |
Dec2024 | ₹162 Cr | -6.92 | |
Sep2024 | ₹175 Cr | -1.28 | |
Jun2024 | ₹177 Cr | 40.16 | |
Mar2024 | ₹126 Cr | -5.55 | |
Dec2023 | ₹134 Cr | -11.30 | |
Sep2023 | ₹151 Cr | 5.81 | |
Jun2023 | ₹142 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -9.02 % |
Y-o-Y | 4.78 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 15.34 % | -9.02 | |
Dec2024 | 16.86 % | -3.38 | |
Sep2024 | 17.45 % | -0.91 | |
Jun2024 | 17.61 % | 20.29 | |
Mar2024 | 14.64 % | -7.46 | |
Dec2023 | 15.82 % | -7.38 | |
Sep2023 | 17.08 % | 7.56 | |
Jun2023 | 15.88 % | - |
JB CHEMICALS & PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -10.43 % |
Y-o-Y | 15.13 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹9.36 | -10.43 | |
Dec2024 | ₹10.45 | -7.03 | |
Sep2024 | ₹11.24 | -1.32 | |
Jun2024 | ₹11.39 | 40.10 | |
Mar2024 | ₹8.13 | -5.68 | |
Dec2023 | ₹8.62 | -11.32 | |
Sep2023 | ₹9.72 | 5.77 | |
Jun2023 | ₹9.19 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD